Overcoming Consent Barriers in Low-Literacy Populations

Introduction: The Challenge of Informed Consent in Low-Literacy Settings

Informed consent is the cornerstone of ethical clinical research, ensuring participants understand the risks, benefits, and responsibilities before joining a trial. However, in populations with low literacy, achieving valid consent is a complex challenge. Participants may struggle to read technical language, comprehend medical terms, or interpret consent forms. According to WHO and ICH-GCP, consent must be obtained in a manner that is understandable to the participant, yet in practice, sponsors often fail to adapt documents adequately. Ethical dilemmas arise when participants agree without fully understanding, jeopardizing the principle of autonomy.

Regulatory Expectations and Ethical Frameworks

Regulators globally recognize the risks of inadequate consent in low-literacy populations. For example:

• ➤ The U.S. Common Rule requires information to be presented in a way that a “reasonable person” would understand
• ➤ The EU Clinical Trials Regulation mandates clear and concise consent materials tailored to the population
• ➤ In India, ethics committees must ensure readability of consent documents in local languages

These frameworks emphasize comprehension, but enforcement varies. A lack of harmonization creates risks in multinational trials, especially in regions with high illiteracy rates.

Communication Barriers in Low-Literacy Populations

Barriers to informed consent extend beyond reading ability. They include cultural, linguistic, and socio-economic factors that influence comprehension:

• ❌ Complex medical terminology that even literate populations struggle with
• ❌ Lack of trust in research institutions, leading to hesitancy in asking clarifying questions
• ❌ Social pressure to comply with community leaders or healthcare providers

These barriers can distort voluntariness and reduce the authenticity of consent, turning the process into a formality rather than a genuine decision-making exercise.

Practical Approaches to Address Consent Challenges

To ensure ethical standards are upheld, sponsors and investigators must implement adaptive measures:

• Use of simple, lay language instead of technical jargon
• Incorporation of visuals such as pictures, diagrams, or videos
• Verbal consent processes, recorded with participant agreement
• Witnessed consent for illiterate participants, ensuring transparency
• Back-translation of documents to confirm accuracy

These approaches are supported by guidance from the World Health Organization ethics guidelines, which stress adaptability to participant needs.

Case Study: eConsent in Low-Literacy Populations

A cancer trial conducted in rural Latin America piloted the use of an electronic consent (eConsent) platform with video explanations in local dialects. Participants could replay videos, hear voiceovers, and discuss with family members before signing. Comprehension tests conducted afterward revealed that 85% of participants could accurately explain the study purpose and risks, compared to only 50% in the paper-based group. This demonstrates how technology, if adapted correctly, can overcome literacy barriers.

Role of Ethics Committees

Ethics committees play a vital role in safeguarding participants in low-literacy settings. Their responsibilities include:

• ➤ Reviewing readability scores of consent forms
• ➤ Ensuring translation into local dialects
• ➤ Verifying the inclusion of visual aids or alternative formats
• ➤ Monitoring recruitment to identify undue influence

Without proactive oversight, sponsors may revert to standardized templates that undermine comprehension.

Conclusion: Ethical Imperatives for Low-Literacy Populations

Informed consent in low-literacy populations is more than a procedural requirement—it is an ethical obligation that demands creativity, sensitivity, and accountability. By simplifying language, incorporating visuals, and strengthening oversight, researchers can honor participants’ rights while ensuring compliance with international standards. Ultimately, genuine informed consent protects vulnerable populations and reinforces the credibility of global clinical trials.

Informed Consent Documentation Variations Across ASEAN Clinical Trials

Informed consent is a cornerstone of ethical clinical research, ensuring participants understand the risks, benefits, and purpose of a study before voluntarily agreeing to participate. In the ASEAN region, informed consent requirements are influenced by each country’s regulations, cultural considerations, and language diversity. Understanding these differences is vital for sponsors, clinical investigators, and regulatory professionals working across multiple jurisdictions.

This article provides a tutorial-style breakdown of the major variations in informed consent documentation across ASEAN countries, with a focus on ethical standards, formatting, language translation, audiovisual requirements, and institutional review board (IRB) expectations. Special attention is given to vulnerable populations, including children and those with limited literacy.

Core Elements of Informed Consent:

According to ICH-GCP and CDSCO standards, the following components are typically required in any informed consent form (ICF):

• Purpose of the study
• Study procedures and duration
• Potential risks and benefits
• Voluntary participation and right to withdraw
• Confidentiality and data protection
• Compensation for injury
• Contact information for inquiries

Country-Specific Consent Documentation Requirements:

1. Singapore:

Governed by the Health Sciences Authority (HSA) and NHG Domain Specific Review Board, Singapore mandates consent forms be written in layperson language (grade 6–8 readability). English is primarily used, but translated versions in Mandarin, Malay, or Tamil are often required depending on the study population.

2. Malaysia:

Malaysia’s Medical Research and Ethics Committee (MREC) insists that ICFs be provided in both English and Bahasa Malaysia. The form must include sections for audio-visual consent documentation when applicable. Templates provided by the Ministry of Health are often used to maintain uniformity.

3. Thailand:

The Thai FDA and local IRBs require ICFs to be in Thai and validated for cultural appropriateness. Consent forms for illiterate participants must be read aloud and documented with thumbprint and witness signature. Assent forms for minors aged 7–17 are mandatory in pediatric trials.

4. Indonesia:

Regulated by Badan POM, Indonesia mandates ICFs in Bahasa Indonesia and requires approval from both the central ethics committee and institutional IRBs. Translations must be certified, and additional forms are required when guardians or legal representatives provide consent.

5. Philippines:

Guided by the Philippine Health Research Ethics Board (PHREB), consent documents must be in English and the local dialect (Tagalog, Cebuano, etc.). If participants cannot read, an impartial witness must sign the consent document. Audiovisual documentation is mandatory for clinical trials involving vulnerable subjects.

6. Vietnam:

The Ministry of Health requires ICFs in Vietnamese, and sponsors must ensure linguistic accuracy. IRBs often request both paper and digital versions of consent documents. Special provisions are made for subjects who are illiterate, elderly, or cognitively impaired.

Key Documentation Differences in ASEAN Trials:

1. Language Translation: Most ASEAN countries require the ICF in both English and the local language. Certified translations are preferred.
2. Witness Requirements: For non-literate populations, a neutral third-party witness is mandatory in Thailand, Indonesia, and the Philippines.
3. Audio-Visual Recording: Malaysia and the Philippines mandate AV recordings for vulnerable populations, especially in high-risk trials.
4. Assent Documentation: Assent forms for minors are explicitly required in Thailand and the Philippines, and encouraged elsewhere.
5. IRB Templates: Malaysia and Vietnam often require the use of IRB-provided ICF templates to standardize content and language.

Special Considerations for Vulnerable Populations:

ASEAN countries are particularly cautious about enrolling vulnerable subjects such as minors, pregnant women, or mentally impaired individuals. In such cases:

• Guardianship documentation is reviewed
• Assent is required from capable minors
• Ethics committees closely review consent content and delivery method

In countries like Vietnam, additional local consent forms may be required for specific disease studies (e.g., TB or HIV).

Common Mistakes and Solutions:

• Omitting Translations: Ensure all ICFs are bilingual with certified translations for target populations.
• Improper Formatting: Follow country-specific templates where available and review IRB SOPs.
• Lack of AV Recording: Confirm whether vulnerable groups require audio-video consent procedures and document accordingly.
• No Assent Process: Include assent procedures and forms for minors and cognitively aware adolescents.

Ethics Committee Review of Informed Consent:

Across ASEAN, ethics committees have the final say in approving the language, structure, and process of obtaining informed consent. Multiple review rounds may be required to address local norms, readability, and regulatory compliance.

For example, the Philippine IRB may insist that certain cultural expressions or superstitions be removed from translations to avoid participant confusion. In Thailand, trial sponsors are expected to submit a “Consent Process Flowchart” outlining how consent is obtained and documented.

Best Practices for Compliance and Quality:

• Use a Pharma SOP for informed consent tailored to each ASEAN country
• Maintain a library of IRB-approved ICF templates per language
• Ensure ongoing training for clinical site staff on GCP-compliant consent delivery
• Audit signed consent forms during monitoring visits
• Document AV consent sessions securely and in compliance with data protection laws

Regular updates based on Stability Studies and regulatory revisions help ensure informed consent materials reflect current science and ethical standards.

Conclusion:

While the ASEAN Clinical Trial Framework promotes harmonization, local regulatory nuances significantly impact how informed consent is documented. Awareness of these differences—and proactively designing consent procedures accordingly—is essential to maintain ethical standards and avoid regulatory delays. Sponsors should partner with local experts, ethics committees, and CROs familiar with regional consent expectations to streamline compliance and improve participant understanding across all ASEAN member states.